LSTM Home > LSTM Research > LSTM Online Archive

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19

Singh, Bhagteshwar, Ryan, H, Kredo, T, Chaplin, Martha and Fletcher, Tom (2020) 'Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19'. Cochrane Database of Systematic Reviews, Vol 4, CD013587.

[img]
Preview
Text
Singh_et_al-2020-Cochrane_Database_of_Systematic_Reviews.pdf - Published Version

Download (207kB) | Preview

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effects of chloroquine (CQ) and hydroxychloroquine (HCQ) as: 1. an antiviral treatment on death and time to clearance of the virus from clinical samples and recovery in people with COVID-19; 2. a prophylactic treatment on prevention of COVID-19 in people at risk of SARS-CoV-2 exposure; 3. a prophylactic treatment on prevention of COVID-19 in people who have been exposed to SARS-CoV-2.

Item Type: Article
Subjects: QV Pharmacology > Anti-Inflammatory Agents. Anti-Infective Agents. Antineoplastic Agents > QV 256 Antimalarials
WA Public Health > WA 100 General works
WA Public Health > WA 105 Epidemiology
WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases
Faculty: Department: Biological Sciences > Department of Tropical Disease Biology
Digital Object Identifer (DOI): https://doi.org/10.1002/14651858.CD013587
Depositing User: Christianne Esparza
Date Deposited: 14 May 2020 12:17
Last Modified: 25 Jan 2022 16:52
URI: https://archive.lstmed.ac.uk/id/eprint/14447

Statistics

View details

Actions (login required)

Edit Item Edit Item